Xlife Sciences AG (SWX:XLS)
Switzerland · Delayed Price · Currency is CHF 14.00
+0.20 (1.45%)
At close: Sep 11, 2026
Xlife Sciences AG Market Cap
Xlife Sciences AG has a market cap or net worth of 78.69 million as of September 11, 2026. Its market cap has decreased by -36.54% in one year.
Market Cap
78.69M
Enterprise Value
224.04M
Revenue
275.31K
Ranking
n/a
PE Ratio
n/a
Stock Price
14.00
ChartMarket Cap Chart
Since February 10, 2022, Xlife Sciences AG's market cap has decreased from 240.46M to 78.69M, a decrease of -67.27%. That is a compound annual growth rate of -21.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 78.69M | -44.76% |
| Dec 30, 2025 | 142.46M | -2.32% |
| Dec 30, 2024 | 145.84M | -47.72% |
| Dec 29, 2023 | 278.96M | 77.76% |
| Dec 30, 2022 | 156.93M | -34.74% |
| Feb 10, 2022 | 240.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bachem Holding AG | 5.77B |
| Idorsia | 1.35B |
| Basilea Pharmaceutica AG | 800.98M |
| Santhera Pharmaceuticals Holding AG | 259.67M |
| Newron Pharmaceuticals | 252.58M |
| BioVersys AG | 167.16M |
| Molecular Partners AG | 127.94M |
| MindMaze Therapeutics Holding | 27.64M |